Although the pathogenesis of NAFLD is not fully understood, it has been shown that hepatic de novo lipogenesis is increased by activation of lipogenic factors such as SREBP-1c, PPARγ, and fatty acid synthase (FASN) [2–5]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.